Contactless Radar Sleep Sensors in 2026: Can Withings and Sleep Number Detect Apnea Without Wearing Anything?

What a Contactless Radar Sleep Apnea Sensor Actually Is

A contactless radar sleep apnea sensor is a device that detects breathing and movement during sleep without anything attached to your body. It sits under your mattress or beside your bed. The promise is simple: track your breathing while you sleep with nothing to wear, charge, or strap on. But here is the catch most reviews skip. Most sensors sold as "radar" in 2026 do not use radar at all. If you are weighing one of these against a wrist device, our guide to wearable sleep trackers in 2026 covers the trade-offs of the strap-on alternatives.

The word "radar" specifically means radio-frequency (RF) sensing. A true radar sensor bounces low-power radio waves off your chest and reads the tiny reflections caused by breathing and heartbeat. Few consumer devices do this. The mainstream products, Withings and Sleep Number, use a different method entirely, which we explain below alongside our smart mattress comparison.

Radar vs Ballistocardiography: The Technology Myth

The sensing technology is the single most important thing buyers misunderstand. Three methods dominate the market, and only one is genuine radar. Knowing which is which tells you what a device can and cannot detect.

Pneumatic and ballistocardiography (most under-mattress mats)

The Withings Sleep Analyzer uses a pneumatic sensor combined with ballistocardiography (BCG). Ballistocardiography reads the tiny mechanical recoil your body makes with each heartbeat and breath. A thin air-filled tube under your mattress senses pressure changes from your chest movements. It is sensitive and clinically validated, but it is not radar.

Embedded BCG strain sensors (smart beds)

Sleep Number's SleepIQ technology embeds ballistocardiography sensors inside the bed. They detect heart rate, breathing rate, and movement, then generate a Sleep Score. Sleep Number states plainly that SleepIQ is not a medical device and makes no apnea claim. It tracks breathing patterns; it does not screen for apnea.

True radar / RF sensing (specialist devices)

The Sleepiz One+ is a genuine radar device. It sits on a bedside table and uses radio-frequency signals to measure breathing and motion across the room. This is the technology people imagine when they hear "contactless radar," yet it is the rarest of the three in consumer channels.

How Accurate Is a Contactless Radar Sleep Apnea Sensor vs PSG?

Validated contactless sensors are surprisingly accurate at flagging moderate-to-severe apnea, though they remain screening tools, not diagnostic ones. Accuracy is measured two ways: sensitivity (how well it catches real cases) and specificity (how well it avoids false alarms), both compared against polysomnography (PSG), the in-lab "gold standard" sleep study.

In a validation study at Hopital Beclere in France, the Withings Sleep Analyzer detected moderate-to-severe sleep apnea (AHI ≥15) with 88% sensitivity and 88.6% specificity versus polysomnography (Journal of Clinical Sleep Medicine, Edouard et al., 2021). That is strong performance for an under-mattress mat.

The radar-based Sleepiz One+ achieved 85% sensitivity and 88.1% specificity for moderate-to-severe OSA without an added oxygen sensor, with an AHI correlation of r=0.87 versus PSG (Sleep and Breathing, Springer, 2024). Adding an SpO2 (blood oxygen) sensor raised this to 87.8% sensitivity, 98.3% specificity, and r=0.94 across 100 participants. Note that these numbers cluster around the AHI ≥15 threshold; both technologies are weaker at detecting milder, AHI 5 to 15 apnea, which matters for the lighter end of the spectrum.

Why a CE-Marked Contactless Radar Sleep Apnea Sensor Matters in the EU

In Europe, the Withings Sleep Analyzer is a CE-marked medical device that reports a clinical AHI grade, which is exactly why the apnea label carries weight for EU buyers. A CE mark on the apnea feature signals that the device met a defined medical standard, not just a wellness benchmark.

The apnea-detection feature is regulated under the EU Medical Device Regulation (EU MDR 2017/745), which sets the bar for any device making a medical claim in Europe. Because Withings cleared that framework for this feature, European users see an actual apnea index rather than a soft, non-clinical wellness score. That distinction is real and worth checking before you buy any contactless sensor in the EU.

Still, a CE-marked sensor is a regulated screening aid, not a diagnostic test. Even with a medical-device label, the result flags risk and prompts a next step. Formal diagnosis in the EU always requires a physician to order and interpret a proper sleep study, regardless of how confident the app display looks.

Screening vs Diagnosis: What These Sensors Can and Cannot Do

A contactless sensor can screen for apnea risk, but only a physician with a validated sleep test can diagnose it. This screen-versus-diagnose line is the most important thing to understand before you buy, because it sets correct expectations and prevents both false alarm and false reassurance.

Screening means flagging that something looks wrong and prompting a next step. Diagnosis means a clinical determination of whether you have OSA, how severe it is, and what treatment fits. In the EU, no consumer sensor performs the second job alone. You do not need a prescription to buy or use a contactless sensor, but you do need a physician to confirm a diagnosis. To understand where wrist wearables sit on this same accuracy spectrum, see our Whoop vs Oura vs Apple Watch accuracy test.

Why Screening Matters: The Undiagnosed Apnea Gap

Contactless sensors matter because most people with sleep apnea have never been diagnosed. The screening gap is enormous, and these devices are well placed to surface risk in people who would otherwise never test.

Obstructive sleep apnoea affects roughly 13% of men and 9% of women in the adult population, and community sleep-disordered breathing prevalence reaches up to ~20% (European Respiratory Society, European Respiratory Journal, 2009). Yet studies suggest a large majority, on the order of 80-90% of people with OSA, remain undiagnosed (International Respiratory Coalition, Global Burden of OSA review, 2025).

Europe shows the gap clearly. In a population-based French cohort, treated sleep apnoea prevalence was only 3.5%, while 18.1% of untreated participants screened positive for OSA (ERJ Open Research, 2023). That is a large untreated population a contactless sensor could nudge toward proper testing.

A Sensor Flagged Me, Now What? The EU Care Pathway

If a contactless sensor flags possible apnea or breathing disturbances, the next step is confirmation by a physician, not self-diagnosis from an app. Few guides close this loop, so here is the EU pathway and the realistic spectrum of options afterward.

This is where the spectrum matters. A sensor tells you that your breathing is disrupted; it does not tell you what to do about it. For snoring and mild-to-moderate OSA, one prescription-free, EU-available option is the Back2Sleep nasal stent, a soft silicone intranasal tube that keeps the upper airway open during sleep. As a CE-certified Class I device, it uses no electricity, noise, or tubing, and the starter kit includes four sizes. It is positioned for snoring and mild-to-moderate cases only; it is not a substitute for diagnosis and not for severe or central apnea. Always confirm a positive screen with a physician before self-treating.

Frequently Asked Questions